Certified by Founder
Lodge
ParcelBio
start up
United States
- San Francisco, California
- 08/05/2026
- Seed
- $13,000,000
ParcelBio is engineering a new class of mRNA medicines designed to deliver unprecedented potency and durability. Its proprietary APEXm™ platform uses novel RNA domains to enhance protein expression and extend activity, enabling therapies that reach the thresholds required for meaningful, and potentially curative, clinical outcomes. The company is advancing programs in autoimmune disease, oncology, and encoded protein therapeutics.
- Industry Biotechnology Research
- Website https://parcelbio.com/
- LinkedIn https://www.linkedin.com/company/parcelbio/
Itera | $12,000,000 | (May 28, 2026)
ClearNote Health | $52,000,000 | (May 28, 2026)
Protuoso Biosciences | $9,500,000 | (May 28, 2026)
Fields Good | $1,800,000 | (May 28, 2026)
Cypher AI | $2,000,000 | (May 28, 2026)
C2i Semiconductors | $16,700,000 | (May 28, 2026)
Orbital Industries | $50,000,000 | (May 28, 2026)
Secretome Therapeutics | $30,000,000 | (May 28, 2026)
Pace(US) | $46,000,000 | (May 28, 2026)
Certo | $4,000,000 | (May 28, 2026)
Mykor | $5,360,920 | (May 28, 2026)
Go Swag | $5,000,000 | (May 27, 2026)